STudy of Aspirin Removal in Patients Supported by the Fully Magnetically Levitated CH-VAD Pump
A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 370 participants.
Also called NCT07644247
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 370 participants
- Sponsor
- Beijing Anzhen Hospital
- China National Center for Cardiovascular Diseases
- Chinese Academy of Medical Sciences, Fuwai Hospital
- First Affiliated Hospital Xi'an Jiaotong University
- First Affiliated Hospital of Xinjiang Medical University
- First Affiliated Hospital of Zhejiang University
- Fujian Provincial Hospital
- Guangdong Provincial People's Hospital
- Henan Provincial Chest Hospital
- Nanjing First Hospital, Nanjing Medical University
- People's Hospital of Xinjiang Uygur Autonomous Region
- Ruijin Hospital
- Second Hospital of Jilin University
- Shanghai Zhongshan Hospital
- Sichuan Provincial People's Hospital
- Sir Run Run Shaw Hospital
- Wuhan Asia Heart Hospital
- Xijing Hospital
- Zhejiang Provincial People's Hospital
- Registry
-
NCT07644247
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07644247. Randomized; quadruple masking; primary purpose treatment. Start 2026-06-25 (anticipated); primary completion 2029-01-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- STudy of Aspirin Removal in Patients Supported by the Fully Magnetically Levitated CH-VAD Pump
- Acronym
- STAR
- Condition
- LVAD (Left Ventricular Assist Device) Thrombosis
- Condition
- LVAD
- Condition
- LVAD (Left Ventricular Assist Device)
- Condition
- LVAD-related GI Bleed
- Condition
- Bleeding
- Condition
- Thrombosis
- Condition
- Stroke
- Condition
- Hemocompatibility-related Adverse Event
- Condition
- Ventricular Assist Device
- Condition
- Aspirin
- Condition
- Antiplatelet Therapy
- Condition
- Antithrombotic Therapy
- Intervention (Drug)
- Warfarin (INR 2-3) with placebo
- Intervention (Drug)
- Warfarin (INR 2-3) with aspirin
- Lead sponsor
- China National Center for Cardiovascular Diseases
- Collaborator
- Beijing Anzhen Hospital
- Collaborator
- Wuhan Asia Heart Hospital
- Collaborator
- Shanghai Zhongshan Hospital
- Collaborator
- Jiangsu Provincial People's Hospital
- Collaborator
- Second Hospital of Jilin University
- Collaborator
- Nanjing First Hospital, Nanjing Medical University
- Collaborator
- Zhejiang Provincial People's Hospital
- Collaborator
- Sir Run Run Shaw Hospital
- Collaborator
- Sichuan Provincial People's Hospital
- Collaborator
- First Affiliated Hospital Xi'an Jiaotong University
- Collaborator
- First Affiliated Hospital of Zhejiang University
- Collaborator
- First Affiliated Hospital of Xinjiang Medical University
- Collaborator
- Fuwai Yunnan Cardiovascular Hospital
- Collaborator
- Guangdong Provincial People's Hospital
- Collaborator
- Henan Provincial Chest Hospital
- Collaborator
- Fujian Provincial Hospital
- Collaborator
- People's Hospital of Xinjiang Uygur Autonomous Region
- Collaborator
- Union hospital of Fujian Medical University
- Collaborator
- Ruijin Hospital
- Collaborator
- The 7th People's Hospital of Zhengzhou
- Collaborator
- Chinese Academy of Medical Sciences, Fuwai Hospital
- Collaborator
- Xijing Hospital
Registry records
Assembled by a program from ROR and ClinicalTrials.gov. No person wrote or checked these pages, and they are counted apart from the pages that people wrote. Lists of trials come from the registry's own coding and may miss trials.
Registry organizations 19
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 53 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 35 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 32 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 9 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 12 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 19 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 4 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 26 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 5 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 15 trials in this atlas.
Record details
- Record id
cardio:ct-nct07644247- Content hash
09e5d035ce8b6d85a7316522d2061e456a12e8421ffb032f124507cdc046610a